ABSTRACT
Background: Prophylactic milrinone is commonly used to prevent Low Cardiac Output Syndrome (LCOS) after pediatric cardiac surgery. This study compares the use of levosimendan with milrinone when used as the primary inotrope following pediatric cardiac surgery. Subjects and Methods: Forty infants undergoing corrective surgery for congenital heart disease were recruited during the study and randomized into two groups (group L and group M). During rewarming, a loading dose of levosimendan or milrinone was administered followed by a 24-hour infusion of the chosen inotrope. Echocardiographic variables were measured postoperatively. Statistical analysis was done with SPSS-20 computer package. Association between the variables was found by independent t test. P < 0.05 was considered statistically significant. Results: Mean age and weight of the patient in Group L was 8.55 ± 5.83 months and 6.05 ± 2.09 kgs, while that in group M was 6.85 ± 3.57 months and 5.26 ± 2.11 kgs. 4 patients (20%) treated with levosimendan had LCOS in comparison with 6 (30%) patients in those treated with milrinone. Echocardiographic parameters in both groups L and M were comparable (cardiac index 3.47 ± 0.76 vs 3.72 ± 1.05 L/min/m2, EF 66.10 ± 7.82% vs 59.34 ± 10.74%, stroke volume index 25.4 ± 6.3 vs 27.74 ± 10.35 mL/m2). The duration of ventilation, ICU stay and hospital stay were lesser in group L (12.75 ± 9.69, 35.95 ± 12.11, 119.10 ± 46.397 vs 23.60 ± 22.03, 51.20 ± 29.92, 140.20 ± 52.65 hours). Conclusions: The incidence of LCOS was lesser in those patients treated with levosimendan, when compared with those treated with milrinone. Cardiac index and stroke volume index were comparable between the two groups. Thus, levosimendan provides a non-inferior alternative to milrinone when used as the primary inotrope following pediatric cardiac surgery.
Subject(s)
Cardiac Surgical Procedures , Pyridazines , Cardiac Output , Cardiac Output, Low/prevention & control , Cardiotonic Agents/therapeutic use , Double-Blind Method , Humans , Hydrazones/therapeutic use , Infant , Milrinone/therapeutic use , Pyridazines/therapeutic use , Simendan , Treatment OutcomeABSTRACT
Coarctation of aorta is the most common cardiovascular cause of secondary hypertension. The condition is correctable although early diagnosis is often not made. We report the case of a 9-year-old child who was admitted with severe intractable abdominal pain as the presenting symptom of post-subclavian coarctation of aorta with hypertension. His pain resolved after control of hypertension with parenteral antihypertensives and the narcotic analgesics. He subsequently underwent transcatheter balloon dilation of the coarctation of aorta and remains well with normal blood pressure on follow-up.